Livzon Pharmaceutical Group Inc (1513)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 22 Oct 2026
Key indicators
| Last close | HKD 20.40 |
|---|---|
| 52-week range | 19.80 – 33.18 |
| Return, 1 month / 3 months | +4.1% / −17.1% |
| Return, 1 year / 3 years | −29.5% / +7.3% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 31.8% |
| Worst drawdown (1 year) | -36.6% |
| Average daily value traded | 33.16M HKD |
| Dividend yield | 13.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Livzon Pharmaceutical Group Inc (1513) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 20.40 on 22 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 888 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 29.5% and over the last three months it fell 17.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 46 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -14.5% | ||
| From 52-week high | -38.0% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.1% | ||
| 6-month return | -18.4% | ||
| 12-month return, skipping the last month | -32.3% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.6% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 33.16M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 78 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 13.9% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −4.6% |
|---|---|
| 1 month | +4.1% |
| 3 months | −17.1% |
| 6 months | −18.4% |
| 1 year | −29.5% |
| 3 years | +7.3% |
| 5 years | +5.1% |
Signals
| 50-day / 200-day average | 20.76 / 23.87 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Oct 2026 | HKD 1.1850 |
| 16 Jun 2026 | HKD 1.6430 |
| 13 Jun 2025 | HKD 1.1988 |
| 8 Jul 2024 | HKD 1.4820 |
| 4 Jul 2023 | HKD 1.7439 |
| 31 May 2022 | HKD 1.5116 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.